These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6653487)

  • 1. [Behavior problems in phenylketonuria. Attempt at a biochemical interpretation based on a personal case and a review of the literature].
    Dalery J; Maillet J; de Villard R
    Encephale; 1983; 9(3):279-90. PubMed ID: 6653487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolism of amino acids and brain proteins in phenylketonuria].
    Borkowska I
    Postepy Biochem; 1979; 25(2):159-68. PubMed ID: 574271
    [No Abstract]   [Full Text] [Related]  

  • 3. [An adult patient with phenylketonuria before and one year after reinstitution of diet therapy].
    Tiefenthaler M; Seidl R; Scheibenreiter S; Wandl-Vergesslich K; Stöckler-Ipsiroglu S
    Wien Klin Wochenschr; 1999 Jan; 111(1):33-6. PubMed ID: 10067268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction.
    Smith I; Clayton BE; Wolff OH
    Lancet; 1975 May; 1(7916):1108-11. PubMed ID: 49470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Status of mineral nutrition in children with phenylketonuria treated by low phenylalanine diet. III. Magnesium].
    Cabalska B; Skorkowska-Zieleniewska J; Nowakowska M; Banaś D
    Pediatr Pol; 1988 Jun; 63(6):337-42. PubMed ID: 3237454
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the status of mineral nutrition of children with phenylketonuria treated by a low-phenylalanine diet. II. Zinc].
    Cabalska B; Skorkowska-Zieleniewska J; Nowakowska M
    Pediatr Pol; 1987 Oct; 62(10):681-6. PubMed ID: 3444685
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term beneficial effects of the phenylalanine-restricted diet in late-diagnosed individuals with phenylketonuria.
    Koch R; Moseley K; Ning J; Romstad A; Guldberg P; Guttler F
    Mol Genet Metab; 1999 Jun; 67(2):148-55. PubMed ID: 10356314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical phenylketonuria in a seven-year-old profoundly retarded girl: development of phenylalanine tolerance, in spite of apparently continued failure to convert phenylalanine to tyrosine.
    Cohn GH; Ouellette EM; Moser HW; Efron ML
    Neurology; 1968 Mar; 18(3):310-1. PubMed ID: 5690427
    [No Abstract]   [Full Text] [Related]  

  • 9. Dietary treatment of destructive behavior associated with hyperphenylalaninemia.
    Baumeister AA; Baumeister AA
    Clin Neuropharmacol; 1998; 21(1):18-27. PubMed ID: 9579281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain phenylalanine measurement in patients with phenylketonuria: a serious diagnostic method or just reading tea leaves?
    Bik-Multanowski M; Pietrzyk JJ
    Mol Genet Metab; 2007 Jul; 91(3):297-8. PubMed ID: 17482495
    [No Abstract]   [Full Text] [Related]  

  • 11. Brain phenylalanine concentrations in phenylketonuria: research and treatment of adults.
    Moats RA; Moseley KD; Koch R; Nelson M
    Pediatrics; 2003 Dec; 112(6 Pt 2):1575-9. PubMed ID: 14654668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating phenylketonuria by a phenylalanine-free diet.
    Start K
    Prof Care Mother Child; 1998; 8(4):109-10. PubMed ID: 9814366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in phenylalanine tolerance during the monitoring of diet therapy of pregnant women with phenylketonuria].
    Hyánek J; Viletová H; Soukup J; Kobilková J; Kubík M; Kunová V
    Cesk Gynekol; 1988 Nov; 53(9):650-3. PubMed ID: 3214867
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phenylketonuria: a children's disease in adulthood].
    de Valk HW; de Sonneville LM; Duran M; Poll-The BT; Erkelens DW
    Ned Tijdschr Geneeskd; 2000 Jan; 144(1):11-5. PubMed ID: 10665298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenylketonuria: metabolic alterations induced by phenylalanine and phenylpyruvate.
    Patel MS; Arinze IJ
    Am J Clin Nutr; 1975 Feb; 28(2):183-8. PubMed ID: 234671
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria.
    Möller HE; Weglage J; Wiedermann D; Ullrich K
    J Cereb Blood Flow Metab; 1998 Nov; 18(11):1184-91. PubMed ID: 9809507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal phenylketonuria.
    Brenton DP
    Eur J Clin Nutr; 1989; 43 Suppl 1():13-7. PubMed ID: 2786806
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of calpastatin, minopontin, NIPSNAP1, rabaptin-5 and neuronatin in the phenylketonuria (PKU) mouse brain: possible role on cognitive defect seen in PKU.
    Surendran S; Tyring SK; Matalon R
    Neurochem Int; 2005 Jun; 46(8):595-9. PubMed ID: 15863237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal phenylketonuria.
    Paprocka J; Jamroz E; Wiktor M; Marszał E
    Wiad Lek; 2009; 62(1):11-7. PubMed ID: 19817251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of treatment of phenylketonuria in a mentally retarded 2-year-old boy].
    Loazyńska B; Siwińska A
    Wiad Lek; 1981 Jul; 34(14):1211-6. PubMed ID: 7331322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.